Find information on thousands of medical conditions and prescription drugs.

Anemia, Pernicious

Pernicious anemia refers to a type of autoimmune anemia. Antibodies are directed against intrinsic factor or parietal cells which produce intrinsic factor. Intrinsic factor is required for vitamin B12 absorption, so impaired absorption of vitamin B12 can result. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

The term pernicious anemia is sometimes used more loosely to include non-autoimmune causes of vitamin B12 deficiency.

Diagnosis

Blood testing typically shows a macrocytic anemia, and low levels of serum vitamin B12. A Schilling test can then be used to distinguish between pernicious anemia, vitamin B12 malabsorption, and vitamin B12 deficiency. Approximately 90% of individuals with pernicious anemia have antibodies for parietal cells, however only 50% of individuals with these antibodies have the disease.

History

The treatment for pernicious anemia was first devised by William Murphy who bled dogs to make them anemic and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and George Whipple then set about to chemically isolate the curative substance and ultimately were able to isolate the vitamin B12 from the liver. For this, all three shared the 1934 Nobel Prize in Medicine. As a result, pernicious anemia is now treated with either vitamin B12 injections (hydroxocobalamin or cyanocobalamin), or large oral doses of vitamin B12, typically between 2 and 4 mg daily.

Maurice Beddow Bayly, an anti-vaccinationist and anti-vivisectionist, campaigned against the use of liver therapy, having failed to recognise the nature of the disease (despite reciting the necessary information) .

Symptoms

Pernicious anemia may cause inflammation of the tongue (glossitis). It is also associated with premature greying, blue eyes, vitiligo, and blood group A.

Treatment

Treatment is with vitamin B12 (hydroxycobalamin or cyanocobalamin) injected intramuscularly. Body stores (in the liver) are refilled with half a dozen injections in the first couple of weeks and then maintenance with monthly to quarterly injections throughout the life of the patient.

B12 has traditionaly been given parenterally to ensure absorption. Alternatively, since it has become appreciated that when B12 given orally in sufficient quantity is absorbed regardless of intrinsic factor or the ileum, oral replacement has emerged as an accepted route. Generally 1000 to 2000 mcg daily is required . By contrast, the typical Western diet contains 5-7 mcg of B12.

Read more at Wikipedia.org


[List your site here Free!]


Oral cobalamin for pernicious anemia
From Nutrition Research Newsletter, 4/1/91

VITAMINS AND HEALTH

ORAL COBALAMIN FOR

PERNICIOUS ANEMIA

In a commentary in the January 2, 1991 issue of JAMA, Frank Lederle of the University of Minnesota discusses the use of oral cobalamin in the treatment of pernicious anemia. He notes that a small but constant proportion of an oral dose of cyanocobalamin is absorbed even in the absence of intrinsic factor, and thus oral therapy can be effective if the dose is high enough (in the range of 1000 [microgram]g daily).

Lederle reports that oral cobalamin therapy (which ceased to be available in the US in the late 1950s but became available again in the early 1970s) is rarely prescribed in the US, although it is widely and successfully used in Sweden. The alternative--monthly cobalamin injections--has important disadvantages, including pain, cost of administering injections, and difficulty in reaching some individuals who are elderly or live alone.

Some medical texts have expressed concerns regarding "upredictable absorbancy, patient compliance and cost" of oral therapy, while acknowledging its effectiveness, particularly when injections are problematic. The author states that these concerns are based primarily on outdated data and need not be serious problems.

In a survey of 245 Minneapolis internists conducted by Lederle, it was revealed that none had used oral cobalamin to treat pernicious anemia, and only 1% had used it to treat dietary cobalamin deficiency. Over 90% believed that a sufficient amount of cobalamin could not be absorbed without intrinsic factor and 94% were unaware of an available effective oral cobalamin therapy. Most said they would welcome the option of oral therapy, stating that it would be their treatment of choice for the majority of their patients with cobalamin deficiency.

Lederle concludes that "it is clear from the Swedish experience and the survey results discussed herein that a wider appreciation of the effectiveness and availability of oral cobalamin therapy would be valuable to American physicians and their patients."

In a related editorial, John Hathcock and Gloria Troendle of the Food and Drug Administration agree that oral cobalamin therapy can be safe and effective but stress that patients must be closely monitored at least in the early months of therapy and cautioned not to consume large amounts of folate. They point out that 50% of the patients of the Minneapolis physicians preferred a monthly injection to a daily pill, and that this preference "may conflict with physicians' apparent willingness to accept oral therapy." Although high-dose oral cobalamin preparations are available over the counter, patients with pernicious anemia or others at risk of cobalamin deficiency should always be treated under the supervision of a physician.

COPYRIGHT 1991 Frost & Sullivan
COPYRIGHT 2004 Gale Group

Return to Anemia, Pernicious
Home Contact Resources Exchange Links ebay